Andrew Toy - Jan 1, 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Chief Executive Officer, Director
Signature
s/ Jessica Kirkland, as Attorney-in Fact
Stock symbol
CLOV
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 04:01 PM
Previous filing
Aug 10, 2022
Next filing
Aug 9, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +9.73M +361.2% $0.00 12.4M Jan 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 1, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 1, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date.

Remarks:

EXHIBIT LIST: EX-24 Power Of Attorney